| Filed On | Filing |
|---|---|
| 04 Aug 2022 |
8-K/A: Other Events
On August 4, 2022, the Company posted an updated corporate presentation on its website at imux.com and filed the presentation as Exhibit 99.2 to the Original 8-K. This Amendment No. 1 to Current Report on Form 8-K/A is being filed to cor... |
| 13 Nov 2020 |
8-K/A: Entry into a Material Definitive Agreement
Reference is made to the Securities Purchase Agreement dated April 23, 2020 (the “Purchase Agreement”) between Immunic, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages thereto (each, inc... |
| 01 Apr 2016 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On July 16, 2015, Vital Therapies, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the appointment of Cheryl L. Cohen to the Company’s Board of Directors (the “Board”) on July 14, 2015. At that time, Ms. Cohen had not ... |
Loading...